Corona vaccine experiments suspended after a volunteer fell ill with an “unexplained” disease

<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body="

The American group said in a statement: "We have temporarily discontinued additional vaccination in all of our clinical trials for an experimental vaccine against Covid 19, Including the entire third phase trial, due to an unexplained illness that one of the study participants contracted".

The company did not disclose the nature of the disease or its symptoms.

و .وضحت "Johnson & Johnson" That under the decision to suspend Clinical trialsAt the end of September, an online registration system was closed to gather 60,000 volunteers to participate in the third and final phase of clinical trials.

The Independent Patient Safety Committee has also been called to investigate this development.

And the group noted in its statement that "The occurrence of unwanted risk events is to be expected in any clinical study, particularly in large studies".

Protocols are provided "Johnson & Johnson" However, if any serious adverse event occurs during the conduct of a study, the study is suspended to verify whether this event is related to the drug being evaluated, and to determine whether the study can be resumed.".

“>

The American group said in a statement: “We have temporarily discontinued the additional vaccination in all our clinical trials for an experimental vaccine against Covid 19, Including the entire trial of the third phase, due to an unexplained disease contracted by one of the study participants.

The company did not disclose the nature of the disease or its symptoms.

And Johnson & Johnson clarified that, under the decision to suspend Clinical trialsAt the end of September, an online registration system was closed to gather 60,000 volunteers to participate in the third and final phase of clinical trials.

The Independent Patient Safety Committee has also been called to investigate this development.

The group pointed out in its statement that “the occurrence of undesired risk events is expected in any clinical study, especially in large studies.”

It provides protocols for “Johnson & Johnson“However, if any serious adverse event occurs during a study, the study is suspended to verify whether this event is related to the drug being evaluated, and to determine whether the study can be resumed.”

.

Share on facebook
Facebook
Share on pinterest
Pinterest
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.